Ranbaxy

Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited. (RLL), was established in the U.S. in 1994. RPI began marketing FDA approved generic products in the U.S. in 1998 after receiving its first FDA approval for Cefaclor, a broad spectrum anti-infective agent. Ranbaxy Laboratories Inc. (RLI), also a wholly owned subsidiary of Ranbaxy Laboratories Limited. (RLL), is the branded prescription division in the U.S.

More Information on this manufacturer can be obtained

http://sebulex.com

Find the wide range of products from

SEBULEX

below